Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an alzheimer's disease transgenic model

Ta Fu Chen, Rwei Fen S. Huang, Sey-En Lin, Jyh Feng Lu, Ming Chi Tang, Ming Jang Chiu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Folic acid deficiency and hyperhomocysteinemia potentiate amyloid-β (Aβ) neuron toxicity. Memantine, an NMDA antagonist used in moderate to severe AD, is considered to be neuroprotective. We propose that folic acid might have a synergistic effect for memantine in protecting neurons from Aβ accumulation. We treated 8-month-old Tg2576 transgenic mice with memantine (30 mg/kg/day) with or without folic acid (8 mg/kg/day) for 4 months. Escape latencies in the Morris water maze were significantly shorter in the folic acid-memantine treatment group Tg(+)-M+F compared to both the non-treatment transgenic controls Tg(+) and the memantine-treatment group Tg(+)-M (both p < 0.05). Analysis of Aβ{40} and Aβ{42} showed lower brain loads in both treatment groups but this did not reach statistical significance. Histopathology analysis showed that Tg(+)-M+F had lower ratios of neuronal damage than Tg(+) (p < 0.001) and Tg(+)-M (p< 0.005). DNA analysis revealed that in the Tg(+)M-+F group, transcription was upregulated in 72 brain genes involved in neurogenesis, neural differentiation, memory, and neurotransmission compared to the Tg(+)-M group. In conclusion, we found that folic acid may potentiate the effect of memantine on spatial learning and neuronal protection. The benefit of combination therapy may be through co-action on the methylation-controlled Aβ production, and modification of brain gene expression.

Original languageEnglish
Pages (from-to)607-615
Number of pages9
JournalJournal of Alzheimer's Disease
Volume20
Issue number2
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Memantine
Folic Acid
Alzheimer Disease
Brain
Folic Acid Deficiency
Neurons
Hyperhomocysteinemia
Neurogenesis
N-Methylaspartate
Amyloid
Synaptic Transmission
Methylation
Transgenic Mice
Spatial Learning
Neuroprotection
Gene Expression
Water
DNA
Genes

Keywords

  • Alzheimer's disease
  • folic acid
  • memantine
  • neuron protection
  • spatial learning
  • transgenic mice

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an alzheimer's disease transgenic model. / Chen, Ta Fu; Huang, Rwei Fen S.; Lin, Sey-En; Lu, Jyh Feng; Tang, Ming Chi; Chiu, Ming Jang.

In: Journal of Alzheimer's Disease, Vol. 20, No. 2, 01.01.2010, p. 607-615.

Research output: Contribution to journalArticle

Chen, Ta Fu ; Huang, Rwei Fen S. ; Lin, Sey-En ; Lu, Jyh Feng ; Tang, Ming Chi ; Chiu, Ming Jang. / Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an alzheimer's disease transgenic model. In: Journal of Alzheimer's Disease. 2010 ; Vol. 20, No. 2. pp. 607-615.
@article{cc95ac3a32b14bccb15c5b323330a8fd,
title = "Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an alzheimer's disease transgenic model",
abstract = "Folic acid deficiency and hyperhomocysteinemia potentiate amyloid-β (Aβ) neuron toxicity. Memantine, an NMDA antagonist used in moderate to severe AD, is considered to be neuroprotective. We propose that folic acid might have a synergistic effect for memantine in protecting neurons from Aβ accumulation. We treated 8-month-old Tg2576 transgenic mice with memantine (30 mg/kg/day) with or without folic acid (8 mg/kg/day) for 4 months. Escape latencies in the Morris water maze were significantly shorter in the folic acid-memantine treatment group Tg(+)-M+F compared to both the non-treatment transgenic controls Tg(+) and the memantine-treatment group Tg(+)-M (both p < 0.05). Analysis of Aβ{40} and Aβ{42} showed lower brain loads in both treatment groups but this did not reach statistical significance. Histopathology analysis showed that Tg(+)-M+F had lower ratios of neuronal damage than Tg(+) (p < 0.001) and Tg(+)-M (p< 0.005). DNA analysis revealed that in the Tg(+)M-+F group, transcription was upregulated in 72 brain genes involved in neurogenesis, neural differentiation, memory, and neurotransmission compared to the Tg(+)-M group. In conclusion, we found that folic acid may potentiate the effect of memantine on spatial learning and neuronal protection. The benefit of combination therapy may be through co-action on the methylation-controlled Aβ production, and modification of brain gene expression.",
keywords = "Alzheimer's disease, folic acid, memantine, neuron protection, spatial learning, transgenic mice",
author = "Chen, {Ta Fu} and Huang, {Rwei Fen S.} and Sey-En Lin and Lu, {Jyh Feng} and Tang, {Ming Chi} and Chiu, {Ming Jang}",
year = "2010",
month = "1",
day = "1",
doi = "10.3233/JAD-2010-1396",
language = "English",
volume = "20",
pages = "607--615",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an alzheimer's disease transgenic model

AU - Chen, Ta Fu

AU - Huang, Rwei Fen S.

AU - Lin, Sey-En

AU - Lu, Jyh Feng

AU - Tang, Ming Chi

AU - Chiu, Ming Jang

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Folic acid deficiency and hyperhomocysteinemia potentiate amyloid-β (Aβ) neuron toxicity. Memantine, an NMDA antagonist used in moderate to severe AD, is considered to be neuroprotective. We propose that folic acid might have a synergistic effect for memantine in protecting neurons from Aβ accumulation. We treated 8-month-old Tg2576 transgenic mice with memantine (30 mg/kg/day) with or without folic acid (8 mg/kg/day) for 4 months. Escape latencies in the Morris water maze were significantly shorter in the folic acid-memantine treatment group Tg(+)-M+F compared to both the non-treatment transgenic controls Tg(+) and the memantine-treatment group Tg(+)-M (both p < 0.05). Analysis of Aβ{40} and Aβ{42} showed lower brain loads in both treatment groups but this did not reach statistical significance. Histopathology analysis showed that Tg(+)-M+F had lower ratios of neuronal damage than Tg(+) (p < 0.001) and Tg(+)-M (p< 0.005). DNA analysis revealed that in the Tg(+)M-+F group, transcription was upregulated in 72 brain genes involved in neurogenesis, neural differentiation, memory, and neurotransmission compared to the Tg(+)-M group. In conclusion, we found that folic acid may potentiate the effect of memantine on spatial learning and neuronal protection. The benefit of combination therapy may be through co-action on the methylation-controlled Aβ production, and modification of brain gene expression.

AB - Folic acid deficiency and hyperhomocysteinemia potentiate amyloid-β (Aβ) neuron toxicity. Memantine, an NMDA antagonist used in moderate to severe AD, is considered to be neuroprotective. We propose that folic acid might have a synergistic effect for memantine in protecting neurons from Aβ accumulation. We treated 8-month-old Tg2576 transgenic mice with memantine (30 mg/kg/day) with or without folic acid (8 mg/kg/day) for 4 months. Escape latencies in the Morris water maze were significantly shorter in the folic acid-memantine treatment group Tg(+)-M+F compared to both the non-treatment transgenic controls Tg(+) and the memantine-treatment group Tg(+)-M (both p < 0.05). Analysis of Aβ{40} and Aβ{42} showed lower brain loads in both treatment groups but this did not reach statistical significance. Histopathology analysis showed that Tg(+)-M+F had lower ratios of neuronal damage than Tg(+) (p < 0.001) and Tg(+)-M (p< 0.005). DNA analysis revealed that in the Tg(+)M-+F group, transcription was upregulated in 72 brain genes involved in neurogenesis, neural differentiation, memory, and neurotransmission compared to the Tg(+)-M group. In conclusion, we found that folic acid may potentiate the effect of memantine on spatial learning and neuronal protection. The benefit of combination therapy may be through co-action on the methylation-controlled Aβ production, and modification of brain gene expression.

KW - Alzheimer's disease

KW - folic acid

KW - memantine

KW - neuron protection

KW - spatial learning

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=77954466984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954466984&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-1396

DO - 10.3233/JAD-2010-1396

M3 - Article

C2 - 20164552

AN - SCOPUS:77954466984

VL - 20

SP - 607

EP - 615

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -